Product Code: ETC13340763 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America mRNA Therapeutics Contract Development Manufacturing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 North America mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 North America mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 North America mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 North America mRNA Therapeutics Contract Development Manufacturing Market, 2021 - 2031 |
6.1 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Process Development, 2021 - 2031 |
6.1.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Analytical Testing, 2021 - 2031 |
6.1.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
6.1.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Formulation Development, 2020 - 2028 |
6.1.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Regulatory Support, 2020 - 2028 |
6.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Vaccines, 2021 - 2031 |
6.2.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Therapeutics, 2021 - 2031 |
6.2.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031 |
6.2.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Protein Replacement Therapy, 2020 - 2028 |
6.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Cancer Treatment, 2021 - 2031 |
6.3.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Rare Diseases, 2021 - 2031 |
6.3.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.3.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Autoimmune Diseases, 2021 - 2031 |
6.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.4.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Contract Manufacturing Organizations, 2020 - 2028 |
6.4.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Clinical Research Organizations, 2020 - 2028 |
6.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Lipid Nanoparticles, 2020 - 2028 |
6.5.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By In Vitro Transcription, 2020 - 2028 |
6.5.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Encapsulation Methods, 2020 - 2028 |
6.5.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By CRISPR Technology, 2020 - 2028 |
6.5.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By AI-Based Quality Control, 2020 - 2028 |
7 North America mRNA Therapeutics Contract Development Manufacturing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.3 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 North America mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
9 North America mRNA Therapeutics Contract Development Manufacturing Market - Export/Import By Countries Assessment |
10 North America mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
10.1 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10.3 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 North America mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
11.1 North America mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2022 |
11.2 North America mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |